bioSyntagma's mission is to end drug resistance in cancer patients and eliminate relapse. The implementation of personalized medicine requires advanced diagnostics that can determine the correct drug/treatment cocktail that is right for each individual's needs. bioSyntagma has developed a tool that provides this level of insight. While the technology can be used for various diseases, they are laser focused on cancer first - and more will follow.